Clinical trial
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With…
NCT00386113 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00386113 |
|---|---|
| Title | Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly |
| Official title | A Phase II, Open, Controlled Study to Evaluate the Reactogenicity and the Immunogenicity of GlaxoSmithKline Biologicals' Adjuvanted Influenza Vaccine in Elderly Adults Previously Vaccinated With Either Fluarix™ or the Adjuvanted Vaccine. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Fluarix and adjuvanted influenza vaccine |
| Enrollment | 74 |
| Start date | Oct 16, 2006 |
| Primary completion | Nov 14, 2006 |
| Completion | Nov 14, 2006 |
| First posted | Oct 11, 2006 |
| Last update posted | Feb 26, 2018 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: